164 related articles for article (PubMed ID: 28056488)
21. Functional Characterization and Anti-Tumor Effect of a Novel Group II Secreted Phospholipase A
Alonazi M; Krayem N; Alharbi MG; Khayyat AIA; Alanazi H; Horchani H; Ben Bacha A
Molecules; 2023 Sep; 28(18):. PubMed ID: 37764293
[TBL] [Abstract][Full Text] [Related]
22. High-affinity selective inhibitor against phospholipase A2 (PLA2): a computational study.
Chinnasamy S; Chinnasamy S; Muthusamy K
J Recept Signal Transduct Res; 2016; 36(2):111-8. PubMed ID: 26422703
[TBL] [Abstract][Full Text] [Related]
23. Design of specific peptide inhibitors of phospholipase A2: structure of a complex formed between Russell's viper phospholipase A2 and a designed peptide Leu-Ala-Ile-Tyr-Ser (LAIYS).
Chandra V; Jasti J; Kaur P; Dey S; Srinivasan A; Betzel Ch; Singh TP
Acta Crystallogr D Biol Crystallogr; 2002 Oct; 58(Pt 10 Pt 2):1813-9. PubMed ID: 12351825
[TBL] [Abstract][Full Text] [Related]
24. Interplay between C1-inhibitor and group IIA secreted phospholipase A
Ferrara AL; Bova M; Petraroli A; Marasco D; Payré C; Fortuna S; Palestra F; Ciardi R; Marone G; Spadaro G; Lambeau G; Loffredo S
Immunol Res; 2023 Feb; 71(1):70-82. PubMed ID: 36385678
[TBL] [Abstract][Full Text] [Related]
25. Molecular dynamics study of secretory phospholipase A2 of Russell's viper and bovine pancreatic sources.
Ramakrishnan C; Subramanian V; Velmurugan D
J Phys Chem B; 2010 Oct; 114(42):13463-72. PubMed ID: 20923223
[TBL] [Abstract][Full Text] [Related]
26. Three-dimensional structure of a presynaptic neurotoxic phospholipase A2 from Daboia russelli pulchella at 2.4 A resolution.
Chandra V; Kaur P; Srinivasan A; Singh TP
J Mol Biol; 2000 Mar; 296(4):1117-26. PubMed ID: 10686108
[TBL] [Abstract][Full Text] [Related]
27. A novel approach to the design of inhibitors of human secreted phospholipase A2 based on native peptide inhibition.
Church WB; Inglis AS; Tseng A; Duell R; Lei PW; Bryant KJ; Scott KF
J Biol Chem; 2001 Aug; 276(35):33156-64. PubMed ID: 11427527
[TBL] [Abstract][Full Text] [Related]
28. Regulation of catalytic function by molecular association: structure of phospholipase A2 from Daboia russelli pulchella (DPLA2) at 1.9 A resolution.
Chandra V; Kaur P; Jasti J; Betzel C; Singh TP
Acta Crystallogr D Biol Crystallogr; 2001 Dec; 57(Pt 12):1793-8. PubMed ID: 11717491
[TBL] [Abstract][Full Text] [Related]
29. Purification, crystallization and preliminary x-ray crystallographic analysis of a phospholipase A2 from Daboia russelli pulchella.
Chandra V; Nagpal A; Srinivasan A; Singh TP
Acta Crystallogr D Biol Crystallogr; 1999 Apr; 55(Pt 4):925-6. PubMed ID: 10089336
[TBL] [Abstract][Full Text] [Related]
30. Isolation and characterization of bioactive compounds of Clematis gouriana Roxb. ex DC against snake venom phospholipase A
Muthusamy K; Chinnasamy S; Nagarajan S; Sivaraman T; Chinnasamy S
J Biomol Struct Dyn; 2017 Jul; 35(9):1936-1949. PubMed ID: 27355444
[TBL] [Abstract][Full Text] [Related]
31. PLA
Borges RJ; Lemke N; Fontes MRM
Sci Rep; 2017 Nov; 7(1):15514. PubMed ID: 29138410
[TBL] [Abstract][Full Text] [Related]
32. Mapping of suramin binding sites on the group IIA human secreted phospholipase A2.
Vieira DS; Aragão EA; Lourenzoni MR; Ward RJ
Bioorg Chem; 2009 Apr; 37(2):41-5. PubMed ID: 19251299
[TBL] [Abstract][Full Text] [Related]
33. Combining in silico and in vitro approaches to identification of potent inhibitor against phospholipase A2 (PLA2).
Chinnasamy S; Selvaraj G; Selvaraj C; Kaushik AC; Kaliamurthi S; Khan A; Singh SK; Wei DQ
Int J Biol Macromol; 2020 Feb; 144():53-66. PubMed ID: 31838071
[TBL] [Abstract][Full Text] [Related]
34. Lipidomics-based assays coupled with computational approaches can identify novel phospholipase A
Mouchlis VD; Mu C; Hammons R; Dennis EA
Adv Biol Regul; 2020 May; 76():100719. PubMed ID: 32199750
[TBL] [Abstract][Full Text] [Related]
35. Structural characterization of myotoxic ecarpholin S from Echis carinatus venom.
Zhou X; Tan TC; Valiyaveettil S; Go ML; Kini RM; Velazquez-Campoy A; Sivaraman J
Biophys J; 2008 Oct; 95(7):3366-80. PubMed ID: 18586854
[TBL] [Abstract][Full Text] [Related]
36. Temperature effect in the inhibition of PLA
Diniz EADS; da Silva DP; Ferreira SS; Fernandes-Pedrosa MF; Vieira DS
J Biomol Struct Dyn; 2024 Jul; 42(10):5238-5252. PubMed ID: 37378497
[TBL] [Abstract][Full Text] [Related]
37. Insights on the structure of native CNF, an endogenous phospholipase A2 inhibitor from Crotalus durissus terrificus, the South American rattlesnake.
Fortes-Dias CL; Ortolani PL; Fernandes CA; Lobo KR; Amaral de Melo L; Borges MH; Pazin WM; Neto Mde O; Fernandez RM; Fontes MR
Biochim Biophys Acta; 2014 Sep; 1844(9):1569-79. PubMed ID: 24820993
[TBL] [Abstract][Full Text] [Related]
38. Comparative structural studies of two natural isoforms of ammodytoxin, phospholipases A2 from Vipera ammodytes ammodytes which differ in neurotoxicity and anticoagulant activity.
Saul FA; Prijatelj-Znidarsic P; Vulliez-le Normand B; Villette B; Raynal B; Pungercar J; Krizaj I; Faure G
J Struct Biol; 2010 Mar; 169(3):360-9. PubMed ID: 19857576
[TBL] [Abstract][Full Text] [Related]
39. Computer-aided drug design guided by hydrogen/deuterium exchange mass spectrometry: A powerful combination for the development of potent and selective inhibitors of Group VIA calcium-independent phospholipase A
Mouchlis VD; Morisseau C; Hammock BD; Li S; McCammon JA; Dennis EA
Bioorg Med Chem; 2016 Oct; 24(20):4801-4811. PubMed ID: 27320659
[TBL] [Abstract][Full Text] [Related]
40. Characterization of suramin binding sites on the human group IIA secreted phospholipase A2 by site-directed mutagenesis and molecular dynamics simulation.
Aragão EA; Vieira DS; Chioato L; Ferreira TL; Lourenzoni MR; Silva SR; Ward RJ
Arch Biochem Biophys; 2012 Mar; 519(1):17-22. PubMed ID: 22248627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
